[Contemporary views on estrogen replacement therapy. II. Hormonal therapy in women with imminent ischemic heart disease].
The frequence of ischemic heart disease occurring increases 2-3 fold in postmenopausal period. It is a result of serum lipid profile changes. Estrogenotherapy restores correct lipid relations and protect coronary vessels in this way, preventing stenocardia and cardiac infarcts. Divergent opinions coexist with including progestogens to estrogen replacement therapy. However a view that well selected doses and kind of hormone effectively enhance serum HDL level, begins to prevail.
Krasomski
G
G
Kliniki Patologii Ciazy WAM Szpitala Połozniczo-Ginekologicznego Centrum Zdrowia Matki Polki.
D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood; D008075:Lipoproteins, HDL / Q000097:blood; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000517:prevention & control*; D017698:Postmenopause / Q000097:blood*
D008055:Lipids; D008075:Lipoproteins, HDL
Współczesne poglady na stosowanie estrogenowej terapii zastepczej. II. Terapia hormonalna u kobiet zagrozonych choroba niedokrwienna serca.